MERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS)
Clinical trial NCT04579666 · TERMINATED
Trial details
- NCT number
- NCT04579666
- Sponsor
- Apellis Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-30
- Primary completion
- 2023-03-31
- Enrollment
- 249
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.